First case report of neoadjuvant gemcitabine and S-1 for locally advanced unresectable duodenal adenocarcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-7793
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
First case report of neoadjuvant gemcitabine and S-1 for locally advanced unresectable duodenal adenocarcinoma ; volume:8 ; number:1 ; day:19 ; month:5 ; year:2022 ; pages:1-5 ; date:12.2022
Surgical case reports ; 8, Heft 1 (19.5.2022), 1-5, 12.2022
- Creator
-
Kimura, Jiro
Sui, Kenta
Tabuchi, Motoyasu
Murokawa, Takahiro
Sakamoto, Shinya
Iwata, Jun
Matsumoto, Manabu
Okabayashi, Takehiro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40792-022-01453-2
- URN
-
urn:nbn:de:101:1-2022072119125701760551
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kimura, Jiro
- Sui, Kenta
- Tabuchi, Motoyasu
- Murokawa, Takahiro
- Sakamoto, Shinya
- Iwata, Jun
- Matsumoto, Manabu
- Okabayashi, Takehiro
- SpringerLink (Online service)
Other Objects (12)
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
Intensified neoadjuvant chemotherapy with nab-paclitaxel plus gemcitabine followed by FOLFIRINOX in a patient with locally advanced unresectable pancreatic cancer
Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy
Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma
Resection of Locally Advanced Pancreatic Neoplasms after Neoadjuvant Chemotherapy with Nab-Paclitaxel and Gemcitabine following FOLFIRINOX Failure
Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
A Case of Streptozocin Monotherapy for Unresectable Duodenal Neuroendocrine Tumor G2
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal
Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
Intensified neoadjuvant chemotherapy with nab-paclitaxel plus gemcitabine followed by FOLFIRINOX in a patient with locally advanced unresectable pancreatic cancer
Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy
Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma
Resection of Locally Advanced Pancreatic Neoplasms after Neoadjuvant Chemotherapy with Nab-Paclitaxel and Gemcitabine following FOLFIRINOX Failure
Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
A Case of Streptozocin Monotherapy for Unresectable Duodenal Neuroendocrine Tumor G2
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal
Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
Intensified neoadjuvant chemotherapy with nab-paclitaxel plus gemcitabine followed by FOLFIRINOX in a patient with locally advanced unresectable pancreatic cancer
Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy
Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma
Resection of Locally Advanced Pancreatic Neoplasms after Neoadjuvant Chemotherapy with Nab-Paclitaxel and Gemcitabine following FOLFIRINOX Failure
Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
A Case of Streptozocin Monotherapy for Unresectable Duodenal Neuroendocrine Tumor G2
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal